High-dose-rate interstitial brachytherapy in early stage oral tongue cancer - 15 year experience from a tertiary care institute.

CONCLUSIONS: Our study recommends treating patients with brachytherapy alone in T1 stage, and demonstrates the need for addressing nodal region either by neck dissection or nodal irradiation in T2 stage patients. Also, the study highlights the need for dose escalation (from the doses used in the study) in both T1 and T2 stage tumors when using interstitial brachytherapy either as sole modality or as a boost. PMID: 26985198 [PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/26985198?dopt=Abstract

Source: Journal of Contemporary Brachytherapy - March 18, 2016 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research